In this final part of the series, let’s look at analyst recommendations and price targets for Monsanto for the next 12 months.
Of the 19 analysts surveyed by Reuters, 11 of them have given Monsanto “strong buy” to “buy” recommendations. Seven have given it “hold” recommendations, and one has given it a “sell” recommendation for the next 12 months.
Let’s look now at the consensus price recommendation for the next 12 months.
On December 7, 2016, Monsanto closed at $105.41 per share. According to the 19 analysts surveyed by Reuters, the median price target for Monsanto over the next 12 months is $126.50, which is ~20.0% higher than its current market price. It appears that, unlike the market, most analysts are optimistic that the Monsanto-Bayer deal will happen.